store at low temperature
store at -20°C
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits its antitumor activity by blocking CD47 and binds primarily to the N-terminal pyroglutamate of CD47, and can be used in combination with other compounds for the treatment of recurrent myeloma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 189.00 | |
5 mg | In stock | $ 578.00 | |
10 mg | In stock | $ 845.00 |
Description | Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits its antitumor activity by blocking CD47 and binds primarily to the N-terminal pyroglutamate of CD47, and can be used in combination with other compounds for the treatment of recurrent myeloma. |
Synonyms | Hu5F9-G4, Magrolimab (anti-CD47) |
Molecular Weight | N/A |
CAS No. | 2169232-81-7 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Magrolimab 2169232-81-7 Others Hu5F9-G4 Magrolimab (anti-CD-47) Magrolimab (anti-CD47) Magrolimab (antiCD47) Magrolimab (anti CD47) anti-CD47 inhibitor inhibit